市場調査レポート
商品コード
1439406
胃内視鏡:世界市場の考察、競合情勢、市場予測(2030年)Gastroendoscopes - Market Insights, Competitive Landscape, and Market Forecast - 2030 |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
胃内視鏡:世界市場の考察、競合情勢、市場予測(2030年) |
出版日: 受注後更新
発行: DelveInsight
ページ情報: 英文 150 Pages
納期: 2~10営業日
|
世界の胃内視鏡の市場規模は、2023年に32億9,000万米ドル、2030年までに48億5,000万米ドルに達し、2024年~2030年の予測期間にCAGRで6.69%の成長が見込まれます。市場は、胃食道逆流症(GORD)のようなさまざまな胃腸疾患の有病率の増加、胃がんや食道がんの有病率の増加、老年人口における胃腸手術の症例の増加、その他の胃内視鏡に関する急速な製品開発活動などの要因により、前向きな市場成長を示しています。
胃内視鏡の市場力学
胃内視鏡市場は、さまざまな理由によって製品需要が伸びており、主な要因の1つは消化器がんの有病率の増加です。World Cancer Research Fund(2018)によると、胃がんは世界で5番目に多いがんです。2018年の同統計によると、胃がんは男性で4番目に多く発生するがんであり、女性では7番目に多く発生するがんです。消化器がんは2018年、世界的に公衆衛生上の大きな問題となっています。予後や生存率は悪性病変の大きさや病期と関係があるため、消化管の腫瘍性病変を早期に発見することは治癒に不可欠です。適切な内視鏡検査により、視覚化はより良好になります。したがって、消化器がんの有病率の増加は、胃内視鏡の需要の増加をもたらし、予測期間の胃内視鏡市場の成長に寄与する見込みです。
胃内視鏡市場の成長をもたらすもう1つの主な要因は、世界中で老年人口が増加していることです。世界保健機関(WHO)のデータによると、2020年に全世界で約10億人が60歳以上となります。さらに、2050年までに60歳以上の老年人口は倍増し、約21億人に達すると予測され、80歳以上の老年人口は2020年~2050年に3倍に増加し、4億2,600万人に達すると推定されています。加齢は消化器疾患の発症に関連する主な危険因子の1つと考えられているため、老年人口の増加は世界中で消化器疾患の患者数の増加につながると予測され、そのことが予測期間における胃内視鏡の需要の増加につながり、胃内視鏡市場の成長を促進します。
上記の要因に加え、歩留まりや診断精度の向上を目的とした上部消化管と下部消化管の両方に使用できるデュアルタイプの胃内視鏡などの新しい胃内視鏡技術の開発など、胃内視鏡の分野における技術の進歩も胃内視鏡市場の成長を後押しすると予測されます。例えば、2022年10月20日、FUJIFILM Healthcare Americas Corporationは、El-740D/Sデュアルチャネル内視鏡の発売を発表しました。FUJIFILMのEI-740D/Sは、上部消化管と下部消化管用途の両方での使用に向け、米国FDAによって認可された最初のデュアルチャネル内視鏡です。したがって、これは主要メーカーが積極的に関与していることを示している可能性があり、胃内視鏡の高い需要をもたらし、それによって予測期間に胃内視鏡市場の成長を前進させる可能性があります。
しかし、内出血、食道、胃、十二指腸の粘膜の裂傷(穿孔)、呼吸や心臓の問題を含む鎮静剤に対する異常反応など、胃内視鏡検査に関連する術後合併症は、胃内視鏡市場成長の一定の抑制要因となる可能性があります。
パンデミックの発生は、外来受診のキャンセルや緊急性のない病院や処置の中断につながっています。その結果、胃内視鏡の定期的な臨床検査や関連処置が減少しました。しかし、COVID-19のワクチン開発により、ロックダウン規制が緩和され経済情勢が正常化したことで、外来受診や医療サービスの再開など、通常の医療サービスが再開され、胃内視鏡市場の製品需要が軌道に乗りました。
胃内視鏡市場のセグメント分析
胃内視鏡市場の製品タイプセグメントでは、予測期間にカプセル内視鏡が胃内視鏡市場で高いシェアを占める見込みです。これは、これらの錠剤に関連する特定の機能によるものと考えられます。カプセルは通常1~2日以内に便と一緒に痛みなく排出されます。小腸のカプセル内視鏡検査は、鎮静剤を必要としないことや、不快感を与えにくいこと、潜在的な合併症が少ないことなど、従来の内視鏡検査よりもいくつかの利点があります。
当レポートでは、世界の胃内視鏡市場について調査分析し、市場規模と予測、促進要因と課題、企業と製品のプロファイルなどを提供しています。
Gastroendoscopes Market By Product Type (Surgical Endoscopes, Capsule Endoscopes, Transnasal Gastroscopes, Dual Channel Gastroscopes, Others), By Device Type (Rigid Endoscopes, Flexible Endoscopes), By Procedure (Upper Gastrointestinal, Lower Gastrointestinal), By End-User (Hospitals, Ambulatory Surgery Centers, Others), by geography is expected to grow at a steady CAGR forecast till 2030 owing to rising prevalence of various gastrointestinal diseases and growing geriatric population
Global Gastroendoscopes market was valued at USD 3.29 billion in 2023, growing at a CAGR of 6.69% during the forecast period from 2024 to 2030 to reach USD 4.85 billion by 2030. The Gastroendoscopes market is witnessing a positive market growth owing to the factors such as the increasing prevalence of various Gastrointestinal diseases such as gastro-oesophageal reflux disease (GORD), growing prevalence of stomach cancer and oesophageal cancer, rising cases of gastrointestinal procedures among the geriatric population, and rapid product development activities with respect to Gastroendoscopes among others.
Gastroendoscopes Market Dynamics:
The Gastroendoscopes market is witnessing a growth in product demand owing to various reasons, one of the key factors being the increasing prevalence of Gastrointestinal Cancer. According to the World Cancer Research Fund 2018, Stomach cancer is the fifth most common cancer worldwide. As per the same statistics in 2018, Stomach cancer is the fourth most commonly occurring cancer in men and the seventh most commonly occurring cancer in women. Gastrointestinal cancer is a major public health problem worldwide in 2018. Detection of early neoplastic lesions in the gastrointestinal tract is essential for a cure because prognosis and survival are related to the size and stage of malignant lesions. With proper endoscopy, visualization becomes better. Therefore, the increasing prevalence of Gastrointestinal Cancer is projected to result in the growing demand for Gastroendoscopes, thereby contributing to the growth of the Gastroendoscopes market during the forecast period.
Another key factor responsible for the growth of the Gastroendoscopes market is the increasing geriatric population base across the globe. According to the data provided by the World Health Organization, in 2020, about one billion people across the world were over the age of 60. The source further stated that by 2050, the elderly population in the 60 and above age group is expected to double in number representing about 2.1 billion people, and people in the age group of 80 and above are estimated to triple between 2020 and 2050 to reach 426 million. Age is considered as one of the key risk factors associated with the development of gastrointestinal diseases, therefore, the rising elderly population is expected to lead to the rise in the patient population of gastrointestinal diseases across the world, which in turn would lead to an increase in demand for Gastroendoscopes in the forecast period, which will drive the Gastroendoscopes market growth.
Along with the factors mentioned above, technological advancements in the field of Gastroendoscopy such as the development of new Gastroendoscopic techniques such as dual types of Gastroendoscopes that can be used for both upper and lower tract with the aim to enhance the yield and diagnostic accuracy are also expected to aid in the growth of the Gastroendoscopes market. For instance, on October 20, 2022, FUJIFILM Healthcare Americas Corporation announced the launch of its El-740D/S dual-channel endoscope. Fujifilm's EI-740D/S is the first dual-channel endoscope cleared by the US FDA for use in both upper and lower gastrointestinal applications. Therefore, this may indicate that the key manufacturers are involved actively and may result in the higher demand for Gastroendoscopes, thereby taking the Gastroendoscopes market growth forward during the forecast period.
However, postoperative complications associated with Gastroendoscopy such as internal bleeding, tearing (perforation) of the lining of the oesophagus, stomach, or duodenum, and abnormal reaction to the sedative, including breathing or heart problems may be certain limiting factors of the Gastroendoscopes market growth.
The outbreak of the pandemic led to the cancellation of outpatient visits and the suspension of non-emergency hospitals and procedures. This resulted in the reduced number of routine clinical examinations of the gastrological visits and related procedures. However, vaccine development of COVID-19 has initiated the process of economic recovery with the easing of lockdown restrictions and the return of normalcy in the economic landscape which has initiated the process of resumption of regular healthcare services such as outpatients visits and resumption of healthcare services, thereby bringing the demand for products on track in the Gastroendoscopes market.
Gastroendoscopes Market Segment Analysis:
Gastroendoscopes Market By Product Type (Surgical Endoscopes, Capsule Endoscopes Transnasal Gastroscopes, Dual Channel Gastroscopes, Others), By Device Type (Rigid Endoscopes, Flexible Endoscopes), By Procedure (Upper Gastrointestinal, Lower Gastrointestinal), By End-User (Hospitals, Ambulatory Surgery Centers, Others), and By Geography (North America, Europe, Asia-Pacific, and Rest of the World)
In the Product Type segment of the Gastroendoscopes market, the Capsule Endoscopes are estimated to hold a higher share in the Gastroendoscopes market during the forecast period. This can be attributed to the specific features associated with these pills. The capsule is usually passed out painlessly with the feces within one to two days. Small Bowel Capsule Endoscopy offers several advantages over traditional endoscopy procedures including it does not require sedation, being less likely to cause discomfort, and having fewer potential complications.
Another added advantage associated with Capsule Endoscopes is that they can be used to access both the upper and lower tract without being restricted to upper-tract applications.
Therefore, considering the advantages associated with Capsule Endoscopes, this product category is expected to generate significant revenue share eventually contributing to the overall growth of the global Gastroendoscopes market in the forecast period.
North America is expected to dominate the overall Gastroendoscopes Market:
Among all the regions, North America is expected to account for the largest share in the Global Gastroendoscopes market. Factors such as the increasing prevalence of various cancers including gastrointestinal cancer, rising government initiatives, and increased product launches are expected to aid in the growth of the North America Gastroendoscopes Market.
Furthermore, high disposable income, sophisticated healthcare infrastructure, increased awareness regarding disease progression and new product launches are also expected to aid in the Gastroendoscopes market growth in this region.
According to the American Cancer Society 2022, in the United States, about 26,560 new cases of stomach cancer (16,160 in men and 10,400 in women) and about 11,180 deaths from this type of cancer (6,740 men and 4,440 women) have been estimated.
Furthermore, according to the same statistics, stomach cancer accounts for about 1.5% of all new cancers diagnosed in the US each year. Therefore, the rising prevalence of stomach cancers in the country would result in the rising demand for treatments that make use of Gastroendoscopes, which in turn would provide a conducive growth environment for the United States Gastroendoscopes market as well as the North American region.
Furthermore, the increased emphasis on product development activities and the high interest of device manufacturers in accessing local markets further aid in the growth of the regional markets for Gastroendoscopes. For instance, on September 23, 2020, CapsoVision announced that the US FDA applied enforcement discretion which allowed at-home administration of the CapsoCam Plus® small bowel capsule endoscope during the COVID-19 pandemic for patients who are determined eligible for at-home administration.
These kinds of product launches in the local markets correlate to a significant reduction in costs, providing at-home care, thereby driving the product demand in the market. Therefore, the interplay of various factors such as the presence of a large patient population, encouraging reimbursement policies as well as new product launches in the region is expected to boost the North America Gastroendoscopes market during the forecast period.
Gastroendoscopes Market Key Players:
Some of the key market players operating in the Gastroendoscopes market include Olympus, Boston Scientific Corporation, CONMED Corporation, Ambu A/S, PENTAX Medical, KARL STORZ SE & Co. KG, Shaili Endoscopy, Stryker, FUJIFILM Healthcare Americas Corporation, Medtronic, Albyn Medical Ltd., Creo Medical, CapsoVision, Inc., Changzhou JIUHONG Medical Instrument Co., Ltd., and others.
Recent Developmental Activities in Gastroendoscopes Market:
On August 18, 2022, The Ambu® aScope(TM) Duodeno received a CE mark and is ready to be used at healthcare centers in Europe. The product was already been commercialized in the USA since December 2020. The aScope(TM) Duodeno is Ambu's first device for GI (gastrointestinal) endoscopy.
On November 3, 2020, ALBYN MEDICAL SL acquired BOUCART MEDICAL Srl., a leading company that distributes endoscopy accessories based in Brussels, Belgium.
On September 1, 2018, ALBYN MEDICAL SL acquired PAULDRACH Medical GmbH, based in Hannover, Germany, a company that distributes endoscopy accessories in German-speaking countries.
Key Takeaways from the Gastroendoscopes Market Report Study
Market size analysis for current Gastroendoscopes market size (2023), and market forecast for 5 years (2024-2030)
The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the Gastroendoscopes market.
Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years
Key companies dominating the global Gastroendoscopes market.
Various opportunities available for the other competitor in the Gastroendoscopes market space.
What are the top performing segments in 2023? How these segments will perform in 2030.
Which is the top-performing regions and countries in the current Gastroendoscopes market scenario?
Which are the regions and countries where companies should have concentrated on opportunities for Gastroendoscopes market growth in the coming future?
Target Audience who can be benefited from this Gastroendoscopes Market Report Study
Gastroendoscopes products providers
Research organizations and consulting companies
Gastroendoscopes-related organizations, associations, forums, and other alliances
Government and corporate offices
Start-up companies, venture capitalists, and private equity firms
Distributors and Traders dealing in Gastroendoscopes
Various End-users who want to know more about the Gastroendoscopes market and latest technological developments in the Gastroendoscopes market.
Frequently Asked Questions for Gastroendoscopes Market:
A Gastroendoscopes is a device that is used in the visualization of the internal anatomy of the oesophagus, stomach, and duodenum.
Global Gastroendoscopes market was valued at USD 3.29 billion in 2023, growing at a CAGR of 6.69% during the forecast period from 2024 to 2030 to reach USD 4.85 billion by 2030.
The Gastroendoscopes market is witnessing a positive market growth owing to the factors such as the increasing prevalence of various Gastrointestinal diseases such as gastro-oesophageal reflux disease (GORD), growing prevalence of stomach cancer and oesophageal cancer, rising cases of gastrointestinal procedures among the geriatric population, and rapid product development activities with respect to Gastroendoscopes among others.
Some of the key market players operating in the Gastroendoscopes market include Olympus, Boston Scientific Corporation, CONMED Corporation, Ambu A/S, PENTAX Medical, KARL STORZ SE & Co. KG, Shaili Endoscopy, Stryker, FUJIFILM Healthcare Americas Corporation, Medtronic, Albyn Medical Ltd., Creo Medical, CapsoVision, Inc., Changzhou JIUHONG Medical Instrument Co., Ltd., and others.
North America is expected to hold the highest share in the revenue in the Gastroendoscopes market during the forecast period. Factors such as the increasing prevalence of various cancers including gastrointestinal cancer, rising government initiatives, and increased product launches are expected to aid in the growth of the North America Gastroendoscopes Market. Furthermore, high disposable income, sophisticated healthcare infrastructure, and increased awareness regarding disease progression and new treatments are also expected to aid in the Gastroendoscopes market growth in this region.